Significant Order for
Environmentally Friendly Agrochemical Material Placed to Fulfill
Initial
Demand;Subsidiary
will House Announced
Asset Acquisition from Global Agrochemicals
Innovator
SOUTH EASTON, MA -- July 21, 2021 -- InvestorsHub
NewsWire -- Pressure
BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a
leader in the development and sale of broadly enabling,
pressure-based instruments, consumables, and platform technology
solutions to the worldwide biotechnology, biotherapeutics,
nutraceuticals, cosmetics, agriculture, and food & beverage
industries, today announced it has established a wholly-owned
agrochemicals subsidiary named PBI Agrochem, Inc. The Company
further announced that it has purchased over a half-million dollars
of specialized, proprietary material to be used to fulfill initial
demand for its eco-friendly and effective agrochemical pest control
and growth stimulant products. Finally, the Company remains focused
on its ongoing efforts and is optimistic that it will complete the
previously announced asset acquisition of a global developer and
supplier of environmentally responsible and organically natural
agrochemicals in the coming weeks, subject to certain conditions,
including the completion of all due diligence and acquisition
financing.
Global population growth is driving a significant increase in
food production demand, which in turn is driving an increased need
for the use of pesticides and fertilizers. Whether from traditional
production-boosting synthetics or the new generation of
eco-friendly agrochemicals, all pesticides and fertilizers face
common challenges in getting oily "active ingredients" (the
material that is going to exert desired effects on the plant or the
pest) to become effectively absorbed, which is required for optimal
bioavailability (or efficacy) within the targeted plant species.
Pesticides, used to control insects that damage crops and severely
limit production, are projected to grow in worldwide sales from
$84.5 billion in 2019 to $131 billion
by 2023.
Fertilizers, used to replenish soil with essential nutrients
required for better crop growth and production, are expected to
achieve global sales of approximately $232 billion by 2025.
PBI's Ultra Shear Technology™ ("UST™") nanoemulsification
platform was specifically designed to make oils effectively soluble
in water. Consequently, UST is expected to enable safer and more
environmentally responsible and effective agrochemical dosing while
reducing the amount and consequently the cost burden of expensive
active ingredients required in agrochemical product
formulations.
Mr. Richard T. Schumacher, President and CEO of PBI, commented:
"Our breakthrough UST platform for processing high value oil-based
active ingredients into superior quality nanoemulsions is expected
to significantly improve absorption and bioavailability of active
oily ingredients, with safer, better controlled, and more
economical dosing delivery to the targeted plants. We believe our
eco-friendly agrochemical products - some to be enhanced by UST
processing - will offer revolutionary changes in product
capabilities and innovation to agriculture customers
worldwide."
Mr. John B. Hollister, Director of Sales and Marketing at PBI,
said: "We have developed a very aggressive yet realistic plan to
expand our business into the eco-friendly agrochemical space, which
is currently over-flowing with growth opportunities. We believe few
areas are hotter than eco-friendly agrochemicals, especially those
that have been designed to minimize the long-term global
environmental impact of persistent or glacially-slow degrading
traditional agrochemicals."
Mr. Hollister added: "We look forward with anticipation to the
close of the asset acquisition. We believe the line of high
quality, eco-friendly agrochemical products being acquired, when
combined with PBI's technical capabilities and innovative
technology platforms, will result in strong product sales with
significant revenue from the new agrochemical business sector for
PBIO, beginning as soon as this current third quarter of 2021."
PBI's Board Chairman, Mr. Jeffrey N. Peterson provided a broader
context: "In addition to our goal of finishing FY2021 with record
strong revenue and a significant decrease in operating loss, we are
also intently focused on two additional objectives: (i) eliminating
from our balance sheet the expensive debt that PBI has necessarily
utilized over the past few years to manage through periods when
more reasonable equity financing was unavailable, and (ii)
up-listing to either NASDAQ or the NYSE at the earliest appropriate
opportunity. We are making excellent progress on both fronts and
look forward to updating PBI's shareholders regularly on these two
very important goals."
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale
of innovative, broadly enabling, pressure-based solutions for the
worldwide life sciences and other industries. Our products are
based on the unique properties of both constant (i.e., static) and
alternating (i.e., pressure cycling technology, or PCT) hydrostatic
pressure. PCT is a patented enabling technology platform that uses
alternating cycles of hydrostatic pressure between ambient and
ultra-high levels to control bio-molecular interactions safely and
reproducibly (e.g., cell lysis, biomolecule extraction). Our
primary focus is in the development of PCT-based products for
biomarker and target discovery, drug design and development,
biotherapeutics characterization and quality control, soil &
plant biology, forensics, and counter-bioterror applications.
Additionally, major new market opportunities have emerged in the
use of our pressure-based technologies in the following areas: (1)
the use of our recently acquired, patented technology from
BaroFold, Inc. (the "BaroFold" technology) to allow entry into the
bio-pharma contract services sector, and (2) the use of our
recently-patented, scalable, high-efficiency, pressure-based Ultra
Shear Technology ("UST") platform to (i) create stable
nanoemulsions of otherwise immiscible fluids (e.g.,oils and water)
and to (ii) prepare higher quality, homogenized, extended
shelf-life or room temperature stable low-acid liquid foods that
cannot be effectively preserved using existing non-thermal
technologies.
Forward Looking Statements
This press release contains forward-looking statements. These
statements relate to future events or our future financial
performance and involve known and unknown risks, uncertainties and
other factors that may cause our or our industry's actual results,
levels of activity, performance, or achievements to be materially
different from any future results, levels of activity, performance
or achievements expressed, implied, or inferred by these
forward-looking statements. In some cases, youcan identify
forward-looking statements by terminology such as "may," "will,"
"should,""could,""would," "expects," "plans,"
"intends,""anticipates," "believes," estimates,""predicts,"
"projects,""potential" or "continue" or the negative of such terms
and other comparable terminology. These statements are only
predictions based on our current expectations and projections about
future events. You should not placeundue reliance on these
statements. In evaluating these statements, you should specifically
consider various factors. Actual events or results may differ
materially. These and other factors may cause our actual results to
differ materially fromany forward-looking statement. These risks,
uncertainties, and other factors include, but are not limited to,
the risks and uncertainties discussed under the heading "Risk
Factors" in the Company's Annual Report on Form 10-K for the year
ended December 31, 2019, and other reports filed by the Company
from time to time with the SEC. The Company undertakes no
obligation to update any of the information included in this
release, except as otherwise required by law.
For more information about PBI and this press release, please
click on the following website link: http://www.pressurebiosciences.com.
Please visit us on Facebook, LinkedIn, and Twitter.
PRESS CONTACTS:
Richard T. Schumacher, President & CEO (508) 230-1828
(T)
John B. Hollister, Director of Sales and Marketing (508) 230 -1828
(T)
Jeffrey N. Peterson, Chairman (650) 703-8557(T)
SOURCE: Pressure BioSciences, Inc.
Grafico Azioni Pressure Biosciences (CE) (USOTC:PBIO)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Pressure Biosciences (CE) (USOTC:PBIO)
Storico
Da Gen 2024 a Gen 2025
